Given that HSPB1 increase has been reported in astrocytes across multiple neurological diseases with astrocyte reactivity, including AD (24,63) and other tauopathies (67–69), Parkinson’s disease (72), or in brain ischemia (73), we can speculate that this is a conserved mechanism across diseases. This evidence concerns the gene HSPB1 and nervous system disorder.